Wilms’ tumor
- References
1. Green, D. M., D’Angio, G. J., Beckwith, J. B., Breslow, N. E., Grundy, P. E., Ritchey, M. L., & Thomas, P. R. M. (1996). Wilms tumor. CA: A Cancer Journal for Clinicians, 46(1), 46–63. https://doi.org/10.3322/CANJCLIN.46.1.46
2. Vujanić, G. M., Sandstedt, B., Harms, D., Leuschner, I., Kelsey, A., & dE Kraker, J. (2002). Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Medical and Pediatric Oncology, 38(2), 79–82. https://doi.org/10.1002/MPO.1276
3. Dome, J. S., Perlman, E. J., & Graf, N. (2014). Risk stratification for wilms tumor: current approach and future directions. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 34, 215–223. https://doi.org/10.14694/EDBOOK_AM.2014.34.215
4. Verschuur, A., Van Tinteren, H., Graf, N., Bergeron, C., Sandstedt, B., & De Kraker, J. (2012). Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 30(28), 3533–3539. https://doi.org/10.1200/JCO.2011.35.8747
5. Van Den Heuvel-Eibrink, M. M., Hol, J. A., Pritchard-Jones, K., Tinteren, H. Van, Furtwängler, R., Verschuur, A. C., Vujanic, G. M., Leuschner, I., Brok, J., Rübe, C., Smets, A. M., Janssens, G. O., Godzinski, J., Ramírez-Villar, G. L., Camargo, B. De, Segers, H., Collini, P., Gessler, M., Bergeron, C., … Graf, N. (2017). Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol. Nature Reviews Urology 2017 14:12, 14(12), 743–752. https://doi.org/10.1038/nrurol.2017.163
6. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2018, based on November 2020 SEER data submission, posted to the SEER web site, April 2021. Bethesda, MD: National Cancer Institute. Available at: https://seer.cancer.gov/csr/1975_2018/. 2. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol 1993;21:172-181. Available at: https://www.ncbi.nlm.nih.gov/pubmed/7680412.
7. Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med 2017;19:e8. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28716159.
8. Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol 2017;18:719-731. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28410997.
9. Gratias EJ, Dome JS, Jennings LJ, et al. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol 2016;34:3189- 3194. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27400937.
10. Irtan S, Ehrlich PF, Pritchard-Jones K. Wilms tumor: "State-of-the-art" update, 2016. Semin Pediatr Surg 2016;25:250-256. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27955727.
11. Coppes MJ, Arnold M, Beckwith JB, et al: Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer 85:1616-25, 1999
12. Servaes S, Khanna G, Naranjo A, et al. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol 2015;45:166-172. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25135711.
13. Grundy, P. E., Green, D. M., Dirks, A. C., Berendt, A. E., Breslow, N. E., Anderson, J. R., & Dome, J. S. (2012). Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: A report from the Children’s Oncology Group. Pediatric Blood & Cancer, 59(4), 631–635. https://doi.org/10.1002/PBC.24123
14. Shamberger, R. C., Guthrie, K. A., Ritchey, M. L., Haase, G. M., Takashima, J., Beckwith, J. B., D’Angio, G. J., Green, D. M., & Breslow, N. E. (1999). Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Annals of Surgery, 229(2), 292–297. https://doi.org/10.1097/00000658-199902000-00019
15. Gow KW, Roberts IF, Jamieson DH, et al. Local staging of Wilms' tumor--computerized tomography correlation with histological findings. J Pediatr Surg 2000;35:677-679. Available at: https://www.ncbi.nlm.nih.gov/pubmed/10813321.
16. Kieran K, Ehrlich PF. Current surgical standards of care in Wilms tumor. Urol Oncol 2016;34:13-23. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26122713. Kieran K, Anderson JR, Dome JS, et al.: Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5. J Pediatr Surg 47 (4): 700-6, 2012. [PUBMED Abstract]
17. Vujanić, G. M., Gessler, M., Ooms, A. H. A. G., Collini, P., Coulomb-l’Hermine, A., D’Hooghe, E., de Krijger, R. R., Perotti, D., Pritchard-Jones, K., Vokuhl, C., van den Heuvel-Eibrink, M. M., & Graf, N. (2018). The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nature Reviews. Urology, 15(11), 693–701. https://doi.org/10.1038/S41585-018-0100-3
18. Jackson, T. J., Brisse, H. J., Pritchard-Jones, K., Nakata, K., Morosi, C., Oue, T., Irtan, S., Vujanic, G., van den Heuvel-Eibrink, M. M., Graf, N., & Chowdhury, T. (2022). How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group. Pediatric Blood & Cancer, 69(9). https://doi.org/10.1002/PBC.29702
19. D'Angio GJ, Breslow N, Beckwith JB, et al: Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 64:349-60, 1989
20. Dix, D. B., Seibel, N. L., Chi, Y. Y., Khanna, G., Gratias, E., Anderson, J. R., Mullen, E. A., Geller, J. I., Kalapurakal, J. A., Paulino, A. C., Perlman, E. J., Ehrlich, P. F., Malogolowkin, M., Gastier-Foster, J. M., Wagner, E., Grundy, P. E., Fernandez, C. V., & Dome, J. S. (2018). Treatment of stage IV favorable histology wilms tumor with lung metastases: A report from the children’s oncology group AREN0533 study. Journal of Clinical Oncology, 36(16), 1564–1570. https://doi.org/10.1200/JCO.2017.77.1931
21. Dix, D. B., Gratias, E. J., Seibel, N., Anderson, J. R., Mullen, E. A., Geller, J. I., Khanna, G., Kalapurakal, J. A., Perlman, E. J., Ehrlich, P. F., Malogolowkin, M. H., Grundy, P. E., & Dome, J. (2014). Treatment of stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: A report from Children’s Oncology Group study AREN0533. Journal of Clinical Oncology, 32(15_suppl), 10001–10001. https://doi.org/10.1200/JCO.2014.32.15_SUPPL.10001
22. Armstrong AE, Daw NC, Renfro LA, et al. Treatment of focal anaplastic Wilms tumor (FAWT): A report from the Children’s Oncology Group (COG) AREN0321 and AREN03B2 studies. J Clin Oncol 2023;41:10005-10005. Available at: https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.10005.
23. Daw N, Chi YY, Kim Y, et al. Treatment of stage I anaplastic Wilms’tumor: a report from the Children’s Oncology Group AREN0321 study.Eur J Cancer. 2019;118:58-66.12.
24. Dome JS, Cotton CA, Perlman EJ, et al: Treatment of anaplastic histology Wilms’ tumor: Results from the fifth National Wilms’ Tumor Study. J Clin Oncol 24:2352-2358, 2006
25. Graf, N., Tournade, M. F., & De Kraker, J. (2000). THE ROLE OF PREOPERATIVE CHEMOTHERAPY IN THE MANAGEMENT OF WILMS’ TUMOR: The SIOP Studies. Urologic Clinics of North America, 27(3), 443–454. https://doi.org/10.1016/S0094-0143(05)70092-6
26. Rutigliano DN, Kayton ML, Steinherz P, et al.: The use of preoperative chemotherapy in Wilms' tumor with contained retroperitoneal rupture. J Pediatr Surg 42 (9): 1595-9, 2007. [PUBMED Abstract]
27. Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001;19:488-500. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11208843.
28.Van Den Heuvel-Eibrink, M. M., Van Tinteren, H., Bergeron, C., Coulomb-L’Hermine, A., De Camargo, B., Leuschner, I., Sandstedt, B., Acha, T., Godzinski, J., Oldenburger, F., Gooskens, S. L., De Kraker, J., Vujanic, G. M., Pritchard-Jones, K., & Graf, N. (2015). Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). European Journal of Cancer, 51(4), 498–506. https://doi.org/10.1016/J.EJCA.2014.12.011
29. Ehrlich, P., Chi, Y. Y., Chintagumpala, M. M., Hoffer, F. A., Perlman, E. J., Kalapurakal, J. A., Warwick, A., Shamberger, R. C., Khanna, G., Hamilton, T. E., Gow, K. W., Paulino, A. C., Gratias, E. J., Mullen, E. A., Geller, J. I., Grundy, P. E., Fernandez, C. V., Ritchey, M. L., & Dome, J. S. (2017). Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children’s Oncology Group. Annals of Surgery, 266(3), 470–478. https://doi.org/10.1097/SLA.0000000000002356
30. Shamberger RC, Haase GM, Argani P, et al. Bilateral Wilms' tumors with progressive or nonresponsive disease. J Pediatr Surg 2006;41:652- 657; discussion 652-657. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16567171.
31. Benedetti DJ, Varela CR, Renfro LA, et al.: Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5. Cancer 130 (6): 947-961, 2024. [PUBMED Abstract]
32. Stokes CL, Stokes WA, Kalapurakal JA, et al. Timing of radiation therapy in pediatric Wilms tumor: a report from the National Cancer Database. Int J Radiat Oncol Biol Phys 2018;101:453-461.
33. Kalapurakal JA, Li SM, Breslow NE, et al; National Wilms' Tumor Study Group. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys 2003;57:495- 499
34. Thomas PR, Tefft M, Compaan PJ, Norkool P, Breslow NE, D’Angio GJ.Results of two radiation therapy randomizations in the third NationalWilms’ Tumor Study. Cancer. 1991;68(8):1703-1707.
35. Daw NC, Chi YY, Kalapurakal JA, et al. Activity of vincristine andirinotecan in diffuse anaplastic Wilms tumor and therapy outcomes of stage II to IV disease: results of the Children’s Oncology GroupAREN0321 Study. J Clin Oncol. 2020;38(14):1558-1568.
36. Ehrlich PF, Chi YY, Chintagumpala MM, et al. Results of treatment forpatients with multicentric or bilaterally predisposed unilateral Wilmstumor (AREN0534): a report from the Children’s Oncology Group.Cancer. 2020;126(15):3516-3525.
37. Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg 2000;229:292– 297.
38. DM Green, CA Cotton, M Malogolowkin, etal: Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group Pediatr Blood Cancer 48: 493– 499,2007
39. DM Green, CA Cotton, M Malogolowkin, etal: Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group Pediatr Blood Cancer 48: 493– 499,2007
40. Metzger, M. L., Stewart, C. F., Freeman, B. B., Billups, C. A., Hoffer, F. A., Wu, J., Coppes, M. J., Grant, R., Chintagumpala, M., Mullen, E. A., Alvarado, C., Daw, N. C., & Dome, J. S. (2007). Topotecan is active against Wilms’ tumor: results of a multi-institutional phase II study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25(21), 3130–3136. https://doi.org/10.1200/JCO.2007.10.9298
41. B Kremens, B Gruhn, T Klingebiel, etal: High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma Bone Marrow Transplant 30: 893– 898,2002
42. AD Campbell, SL Cohn, M Reynolds, etal: Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: The experience at Children's Memorial Hospital J Clin Oncol 22: 2885– 2890,2004
43. F Spreafico, G Bisogno, P Collini, etal: Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: Experience by the Italian Association of Pediatric Hematology and Oncology Pediatr Blood Cancer 51: 23– 28,2008
44. Brok J, Lopez-Yurda M, Tinteren HV, et al. Relapse of Wilms’ tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group–International Society of Paediatric Oncology Wilms’ tumour protocol database. Lancet Oncol 2018; 19: 1072–81.
45. Jedrzejewski, G., Wozniak, M. M., Pawelec, A., Matera, A., Kunach, M., Madej, T., Wieczorek, A. P., & Nowakowska, K. (2016). Ultrasound screening for neoplasms in children up to 6 years old. Medicine (United States), 95(42). https://doi.org/10.1097/MD.0000000000005124
46. Beckwith, J. B. (1998). National Wilms Tumor Study: An update for pathologists. Pediatric and Developmental Pathology, 1(1), 79–84. https://doi.org/10.1007/S100249900010
47. Liu, E. K., & Suson, K. D. (2020). Syndromic Wilms tumor: a review of predisposing conditions, surveillance and treatment. Translational Andrology and Urology, 9(5), 2370. https://doi.org/10.21037/TAU.2020.03.27
2) Bhatnagar, S. (2009). Management of Wilms’’ tumor: NWTS vs SIOP. Journal of Indian Association of Pediatric Surgeons, 14(1), 6. https://doi.org/10.4103/0971-9261.54811
3) Gratias EJ, Dome JS, Jennings LJ, et al. Association of chromosome 1q gain with inferior survival in favorable-histology Wilms’ tumor: a report from the Children’s Oncology Group. J Clin Oncol 2016;34:3189-3194.
4) Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 2005;23:7312- 7321.
5) Adapted from Wilms’ Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Health Professional Version. National Cancer Institute. Accessed February 2, 2023. Available at: https://www.cancer.gov/types/kidney/hp/Wilms’-treatment-pdq.